Built for the Complexity of Medtech Commercialization
BEC Medical was founded on a simple premise: medical device companies deserve commercialization partners who understand both the science and the business — with the rigor that investors and acquirers demand.
From Innovation to Impact™
BEC Medical is a specialized commercialization advisory firm serving medical device and medtech companies at critical inflection points — pre-launch, pre-raise, and pre-exit. We provide the structured commercial intelligence that founders, boards, and investors require to make high-stakes decisions with confidence.
Our proprietary Commercial Readiness Index™ (CRI™) delivers an objective, scored assessment of commercialization readiness across eight pillars — replacing assumption-driven strategy with measurable, defensible analysis. The output is a prioritized roadmap that aligns your commercial execution with the expectations of institutional investors and strategic acquirers.
BEC Medical operates at the intersection of regulatory expertise, market strategy, and commercial execution. We do not offer generic consulting. Every engagement is built around your device, your market, and your timeline — with accountability for outcomes, not just deliverables.
The BEC Medical Difference
Evidence-Based, Not Opinion-Based
Every recommendation we make is grounded in data. The CRI™ framework eliminates guesswork and replaces it with objective measurement — so you know exactly where you stand and what to do next.
Medtech-Specific Expertise
We don't apply generic consulting frameworks to medical devices. Our team has lived the FDA process, navigated reimbursement complexity, and built commercial organizations inside medtech companies.
Investor and Acquirer Fluency
We understand what institutional investors and strategic acquirers look for — because we've sat on both sides of the table. Our work is designed to build the commercial credibility that drives valuation.
Execution, Not Just Strategy
We don't hand you a slide deck and walk away. Through fractional commercial leadership and embedded engagement models, we stay accountable for outcomes alongside your team.
The Commercial Readiness Index™
A Proprietary Framework for Medtech Commercialization
The CRI™ is the foundation of every BEC Medical engagement. Before recommending a strategy, we measure where you stand — objectively, across all eight commercialization pillars.
The result is a scored baseline that identifies your strengths, exposes your gaps, and prioritizes the initiatives with the greatest commercial impact. It's the kind of rigorous self-assessment that sophisticated investors expect — and that most companies have never done.
Our Principles
Rigor over rhetoric
We measure before we recommend. Data drives every engagement.
Clarity over complexity
Commercialization is hard enough. We make the path forward clear.
Accountability over advice
We stay engaged through execution, not just strategy.
Impact over activity
We focus on the initiatives that move the needle — not the ones that fill a report.
Ready to Work Together?
Schedule a Commercial Readiness Discovery Session and learn how the CRI™ can accelerate your path to market.